June 29, 2022. Avelo wins CHF 150,000 from VentureKick to make every breath count for better respiratory disease diagnosis. The company will use the funds to establish clinical proof and drive its business development activities for successful market access. Further details can be found here.
top of page
Contact
Headquarters & Research Site:
Avelo AG
Rütistrasse 16
CH-8952 Schlieren
Switzerland
Copyright © 2021 by Avelo AG. All rights reserved.
bottom of page
Comments